Exhibit 99.3
INTRODUCTION

On November 21, 2014, the Company completed the purchase of all of the outstanding shares of capital stock of Specialty from its parent, Davidson. Established in 1964 with distribution centers in Mineral Ridge, Ohio and Houston, Texas, Specialty is a master distributor of seamless carbon pipe, with a focus on heavy wall, large diameter products.

The unaudited pro forma condensed combined consolidated balance sheet as of September 27, 2014 combines the historical consolidated balance sheet of the Company as of that date and the historical balance sheet of Specialty as of October 31, 2014 to illustrate the estimated effect of the acquisition on the Company's financial statements as if it had occurred on September 27, 2014. The unaudited pro forma condensed combined consolidated statements of operations combines the historical consolidated statements of operations of the Company for the nine months ended September 27, 2014 and the year ended December 28, 2013 with the historical statements of operations of Specialty for the nine months ended October 31, 2014 and for the year ended October 31, 2013. Both of the consolidated statements of operations of the Company reflect continuing operations only. All costs associated with discontinued operations have been eliminated from the pro forma statements of operations. The unaudited pro forma condensed combined consolidated financial statements are based on certain estimates and assumptions made with respect to the combined operations of the Company and Specialty, which we believe are reasonable. The unaudited pro forma condensed combined consolidated statements of operations are presented for illustrative purposes only and do not purport to be indicative of the results of operations of the Company or Specialty that actually would have been achieved had the acquisition of Specialty been completed on the assumed dates, or to project the Company's results of operations for any future date or period. The unaudited pro forma condensed combined consolidated statements of operations give pro forma effect to the acquisition as if it had occurred on the first day of the financial period presented.

The transaction is being accounted for using the acquisition method of accounting for business combinations in accordance with generally accepted accounting principles in the United States of America. Under this method, the total consideration transferred to consummate the acquisition is allocated to the identifiable tangible and intangible assets acquired and liabilities assumed based on their respective fair values as of the closing date of the acquisition. The acquisition method of accounting requires extensive use of estimates and judgments to allocate the consideration transferred to the identifiable tangible and intangible assets, if any, acquired and liabilities assumed. Accordingly, the allocation of the consideration transferred in the unaudited pro forma condensed combined consolidated financial statements is preliminary and will be adjusted upon completion of the final valuation of the assets acquired and liabilities assumed. Such adjustments could be significant. The final valuation is expected to be completed as soon as practicable but no later than twelve months after the closing date of the acquisition. The unaudited condensed combined consolidated pro forma statements of operations do not include the costs that the Company may incur to integrate Specialty, and these costs may be material.

The historical consolidated financial statements of the Company have been adjusted in the unaudited pro forma condensed combined consolidated financial statements to give effect to pro forma events that are (i) directly attributable to the acquisition, (ii) factually supportable, and (iii) expected to continually impact the combined results of the Company and Specialty. The unaudited pro forma condensed combined consolidated financial statements should be read in conjunction with the accompanying notes to the unaudited pro forma condensed combined consolidated financial statements. In addition, the unaudited pro forma condensed combined consolidated financial statements were derived from, and should be read in conjunction with, the information for the nine months ended September 27, 2014 included in the Company's Quarterly Report on Form 10-Q for the quarter ended September 27, 2014 and the Annual Report on Form 10-K for the year ended December 28, 2013.

The historical condensed combined financial information regarding Specialty that is included in this report has been prepared by and is the responsibility of the Company. In addition, we are in the process of reviewing Specialty's financial statement classifications for conformity with the Company's classifications. As a result of this review, it may be necessary to make additional reclassifications to the consolidated information on a prospective basis.

The statements contained in these notes that are not historical facts are forward-looking statements that involve risks and uncertainties. We wish to caution the reader that these forward-looking statements, such as our expectations for future sales results or future expense changes compared with previous periods, are only predictions. These forward-looking statements may be generally identified by the use of forward-looking words and phrases such as “will,” “intends,” “may,” “believes,” “anticipates,” “should” and “expects,” and are based on our current expectations or beliefs concerning future events that involve risks and uncertainties. Actual events or results may differ materially as a result of risks and uncertainties as described in “Item 1A. Risk Factors” in the Company's Quarterly Report on Form 10-Q for the nine months ended September 27, 2014 and the Annual Report on Form 10-K for the year ended December 28, 2013, other risks referenced in our Securities and Exchange Commission filings, or other unanticipated risks. We disclaim any obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

1



Synalloy Corporation and Subsidiaries
Unaudited Pro Forma Condensed Combined Consolidated Balance Sheet
 
Synalloy
 
Specialty
 
Pro Forma
 
Sep 27,
 
Oct 31,
 
 
 
 
 
2014
 
2014
 
Adjustments
 
Total
Assets
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
Cash and cash equivalents
$
20,747,522

 
$
101

 
$
(21,490,433
)
(5)
$
(742,810
)
Accounts receivable, net
29,645,862

 
2,931,433

 

 
32,577,295

Inventories, net
48,047,605

 
16,381,600

 
(1,520,707
)
(3)
62,908,498

Deferred income taxes
4,011,318

 

 

 
4,011,318

Prepaid expenses and other current assets
4,297,478

 
1,302

 

 
4,298,780

     Total current assets
106,749,785

 
19,314,436

 
(23,011,140
)
 
103,053,081

 
 
 
 
 
 
 
 
Cash value of life insurance
2,079,419

 

 

 
2,079,419

 
 
 
 
 
 
 
 
 
 
 
 
 
(47,924
)
(3)
 
Property, plant & equipment, net
34,426,532

 
2,946,171

 
110,689

(4)
37,435,468

 
 
 
 
 
 
 
 
 
 
 
 
 
(4,103,082
)
(1)
 
Goodwill
17,252,678

 
4,103,082

 
9,630,705

(7)
26,883,383

 
 
 
 
 
 
 
 
 
 
 
 
 
(2,119,222
)
(1)
 
Intangible asset, net
5,962,500

 
2,119,222

 
6,835,000

(7)
12,797,500

Deferred charges, net and other non-current assets
428,865

 

 

 
428,865

 
 
 
 
 
 
 
 
Total assets
$
166,899,779

 
$
28,482,911

 
$
(12,704,974
)
 
$
182,677,716

 
 
 
 
 
 
 
 
Liabilities and shareholders' equity
 
 
Current liabilities
 
 
 
 
 
 
 
Current portion of long-term debt
$
2,533,908

 
$

 
$
2,000,000

(5)
$
4,533,908

Accounts payable
14,118,095

 
1,096,920

 

 
15,215,015

Accrued expenses
12,366,051

 
561,385

 
2,183,579

(10)
15,111,015

Deferred income taxes

 
2,894,059

 
(3,744,663
)
(11)
(850,604
)
Other current liabilities
173,996

 

 

 
173,996

     Total current liabilities
29,192,050

 
4,552,364

 
438,916

 
34,183,330

 
 
 
 
 
 
 
 
Long-term debt
19,004,280

 

 
8,000,000

(5)
27,004,280

Long-term contingent consideration

 

 
2,590,041

(10)
2,590,041

Deferred income taxes
7,177,046

 
1,297,080

 
(1,297,080
)
(11)
7,177,046

Other long-term liabilities
1,574,179

 

 
 
 
1,574,179

 
 
 
 
 
 
 
 
Shareholders' equity
 
 
 
 
 
 
 
  Common stock
10,300,000

 

 

 
10,300,000

  Invested equity

 
22,633,467

 
(22,633,467
)
(2)

  Capital in excess of par value
33,938,122

 

 

 
33,938,122

  Retained earnings
79,792,653

 

 
196,616

(13)
79,989,269

  Less cost of common stock in treasury
(14,078,551
)
 

 

 
(14,078,551
)
     Total shareholders' equity
109,952,224

 
22,633,467

 
(22,436,851
)
 
110,148,840

Commitments and contingencies
 
 
 
 
 
 
 
Total liabilities and shareholders' equity
$
166,899,779

 
$
28,482,911

 
$
(12,704,974
)
 
$
182,677,716

See accompanying notes to unaudited pro forma condensed combined consolidated financial statements.

2



Synalloy Corporation and Subsidiaries
Unaudited Pro Forma Condensed Combined Consolidated Statements of Operations
 
For the Nine Months Ended
 
Synalloy
 
Specialty
 
Pro Forma
 
Sep 27,
 
Oct 31,
 
 
 
 
 
2014
 
2014
 
Adjustments
 
Total
Net sales
$
150,935,909

 
$
24,285,250

 
$

 
$
175,221,159

 
 
 
 
 
 
 
 
Cost of goods sold
125,565,826

 
16,492,784

 

 
142,058,610

 
 
 
 
 
 
 
 
Gross profit
25,370,083

 
7,792,466

 

 
33,162,549

 
 
 
 
 
 
 
 
 
 
 
 
 
(497,121
)
(1)
 
 
 
 
 
 
640,781

(8)
 
Selling and administrative expense
12,108,703

 
3,437,099

 
(447,653
)
(9)
15,241,809

 
 
 
 
 
 
 
 
Operating income
13,261,380

 
4,355,367

 
303,993

 
17,920,740

 
 
 
 
 
 
 
 
Other (income) and expense
 
 
 
 
 
 
 
 
 
 
 
 
132,960

(6)
 
  Interest expense
788,854

 

 
60,633

(10)
982,447

  Acquisition costs
(2,936
)
 

 

 
(2,936
)
  Palmer earn-out adjustment
(3,476,197
)
 

 

 
(3,476,197
)
  Change in fair value of interest rate swap
191,527

 

 

 
191,527

  Other, net
(6,796
)
 

 

 
(6,796
)
Income from continuing operations before income taxes
15,766,928

 
4,355,367

 
110,400

 
20,232,695

Provision for income taxes
4,557,000

 
1,485,000

 
114,000

(12)
6,156,000

 
 
 
 
 
 
 
 
Net income from continuing operations
11,209,928

 
2,870,367

 
(3,600
)
(13)
14,076,695

 
 
 
 
 
 
 
 
Net income per common share from continuing operations:
 
 
 
 
 
 
  Basic
$
1.29

 
 
 
 
 
$
1.62

  Diluted
$
1.29

 
 
 
 
 
$
1.62

 
 
 
 
 
 
 
 
Weighted average shares outstanding:
 
 
 
 
 
 
 
   Basic
8,699,428

 
 
 
 
 
8,699,428

    Dilutive effect from stock options and grants
15,782

 
 
 
 
 
15,782

   Diluted
8,715,210

 
 
 
 
 
8,715,210











See accompanying notes to unaudited pro forma condensed combined consolidated financial statements.

3



Synalloy Corporation and Subsidiaries
Unaudited Pro Forma Condensed Combined Consolidated Statement of Operations

 
For the Years Ended
 
Synalloy
 
Specialty
 
Pro Forma
 
Dec 28,
 
Oct 31,
 
 
 
 
 
2013
 
2013
 
Adjustments
 
Total
Net sales
$
196,751,175

 
$
27,818,797

 
$

 
$
224,569,972

 
 
 
 
 
 
 
 
Cost of goods sold
176,953,036

 
17,824,956

 

 
194,777,992

 
 
 
 
 
 
 
 
Gross profit
19,798,139

 
9,993,841

 

 
29,791,980

 
 
 
 
 
 
 
 
 
 
 
 
 
(874,037
)
(1)
 
 
 
 
 
 
854,375

(8)
 
Selling and administrative expense
16,034,428

 
4,596,290

 
(496,054
)
(9)
20,115,002

 
 
 
 
 
 
 
 
Operating income
3,763,711

 
5,397,551

 
515,716

 
9,676,978

 
 
 
 
 
 
 
 
Other (income) and expense
 
 
 
 
 
 
 
 
 
 
 
 
195,352

(6)
 
  Interest expense
1,357,328

 

 
145,199

(10)
1,697,879

  Acquisition related costs
264,186

 

 

 
264,186

  Change in fair value of interest rate swap
(740,832
)
 

 

 
(740,832
)
  Gain on bargain purchase, net of taxes
(1,077,332
)
 

 

 
(1,077,332
)
  Other, net
(147,687
)
 

 

 
(147,687
)
 
 
 
 
 
 
 
 
Income from continuing operations before income taxes
4,108,048

 
5,397,551

 
175,165

 
9,680,764

 
 
 
 
 
 
 
 
Provision for income taxes
1,048,000

 
1,840,000

 
155,000

(12)
3,043,000

 
 
 
 
 
 
 
 
Net income from continuing operations
$
3,060,048

 
$
3,557,551

 
$
20,165

(13)
$
6,637,764

 
 
 
 
 
 
 
 
Net income per common share:
 
 
 
 
 
 
 
  Basic
$
0.44

 
 
 
 
 
$
0.96

  Diluted
$
0.44

 
 
 
 
 
$
0.96

 
 
 
 
 
 
 
 
Weighted average shares outstanding:
 
 
 
 
 
 
 
   Basic
6,941,794

 
 
 
 
 
6,941,794

      Dilutive effect from stock options and grants
5,610

 
 
 
 
 
5,610

   Diluted
6,947,404

 
 
 
 
 
6,947,404







See accompanying notes to unaudited pro forma condensed combined consolidated financial statements.

4



NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED CONSOLIDATED FINANCIAL STATEMENTS
The purchase price for the acquisition was $31,490,433. The seller has the ability to receive earn-out payments of up to $5,000,000 if the business unit achieves targeted sales levels over the two-year period following closing.

A summary of sources and uses of proceeds for the acquisition is as follows:

Sources of Funds:
 
Cash on hand
$
21,490,433

Proceeds of term loan
10,000,000

Total sources of funds
$
31,490,433

 
 
Uses of Funds:
 
Acquisition of Specialty's common stock
$
27,496,000

Cash paid to escrow agent for potential future claims, to be settled within 18 months
3,248,500

Cash paid for portion of seller's investment banker fee
745,933

Total uses of funds
$
31,490,433


A portion of the purchase price for the Specialty acquisition was funded through a new five-year term loan with the Company's bank.

The total consideration transferred is allocated to Specialty's net tangible and identifiable intangible assets based on their fair value as of November 21, 2014 for purposes of the pro forma condensed combined consolidate financial statements. These amounts are subject to change based on the results of the final valuations of assets acquired and liabilities assumed, which are expected to be completed within the twelve months following the acquisition. The excess of the consideration transferred over the fair value of the net tangible and identifiable intangible assets is reflected as goodwill. The preliminary allocation of the total consideration paid to the fair value of the assets acquired and liabilities assumed as of November 21, 2014 is as follows:

Accounts receivable, net
$
2,827,251

Inventories, net
15,524,772

Property, plant and equipment, net
2,950,492

Deferred tax assets
985,000

Customer list
6,835,000

Goodwill
9,630,705

Contingent consideration
(4,773,620
)
Other liabilities assumed
(2,489,167
)
 
$
31,490,433



5



Pro Forma Adjustments and Assumptions
(1
)
 
Represents the elimination of historical intangible assets and related amortization.
(2
)
 
Represents the elimination of Specialty's historical invested equity account balance in purchase accounting.
(3
)
 
Represents the fair value adjustment to the carrying value of Specialty's inventory, land and building.
(4
)
 
Represents leased equipment purchased at acquisition.
(5
)
 
Represents cash used to purchase Specialty plus additional borrowings provided by a five-year variable rate term note.
(6
)
 
Represents additional interest expense associated with the variable interest rate term note.
(7
)
 
Represents goodwill and other intangible assets associated with the Specialty acquisition.
(8
)
 
Represents amortization of the customer list intangible.
(9
)
 
Represents the elimination of the prior owner's management fees.
(10
)
 
Represents the contingent consideration liabilities to the seller and resultant interest expense.
(11
)
 
Represents the deferred tax liabilities that will not be assumed by Synalloy, i.e., LIFO inventory reserve, intangible asset amortization, depreciation.
(12
)
 
Represents adjustment of income tax expense based upon Specialty's addition to the consolidated Synalloy tax provision calculation.
(13
)
 
Represents impact on net income as a result of pro forma adjustments recognized.
    
Reclassifications

Certain Specialty accounts for the nine months ended October 31, 2014 and for the year ended October 31, 2013 have been reclassified to conform to the Company's presentation in the accompanying pro forma condensed combined consolidated statements of operations. These reclassifications had no material effect on previously reported results of operations or invested equity.

6